While there may have been basic consensus on the multi-sector Trans-Pacific Partnership, the final detailed provisions and wording of the massive trade agreement as it pertains to data exclusivity for biologic medicines have yet to be publicly released.
TPP: ‘Missed Opportunity’ Or ‘Unprecedented Assault’?
Some form of consensus among the 12 countries taking part in the Trans-Pacific Partnership free trade talks may have been reached on the highly charged issue of biologics' exclusivity, but there is still a lack of transparency on the details while the basic deal seems to be satisfying no one outside the closed circle of negotiators.